Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Controlled Human Infection Model for Assessment of SARS-CoV-2 Omicron Subvariants

NCT07397455 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT07397455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07397455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Controlled Human Infection Model for Assessment of SARS-CoV-2 Omicron Subvariants
Lead sponsor
Imperial College London
Phase
Phase 1
Overall status
Recruiting
Start date
July 10, 2026
Completion date
December 31, 2028
Enrollment
38 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2 (covid-19)